Update on percutaneous and perventricular device closure of congenital ventricular septal defect

References

• Allen HD, Clark EB, Driscoll HPG DJ. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult. 6th ed. Philadelphia PA: Lippincott Williams & Wilkins; 2001.
   Google Scholar
• Soto B, Becker AE, Moulaert AJ, et al. Classification of ventricular septal defects. Br Heart J. 1980;43(3):332.
   PubMedGoogle Scholar
• Rudolph AM. Congenital diseases of the heart: clinical-physiological considerations. 2nd ed. Armonk NY: Futura Publishing Co.; 2001.
   Google Scholar
• Stark J, Gallivan S, Lovegrove J, et al. Mortality rates after surgery for congenital heart defects in children and surgeons’ performance. Lancet. 2000;355(9208):1004–1007. DOI:10.1016/S0140-6736(00)90001-1
   PubMed Web of Science ®Google Scholar
• Jacobs JP, He X, Mayer JE, et al. Mortality trends in pediatric and congenital heart surgery: an analysis of the society of thoracic surgeons congenital heart surgery database. Ann Thorac Surg. 2016;102(4):1345–1352. DOI:10.1016/j.athoracsur.2016.01.071
   PubMed Web of Science ®Google Scholar
• Lock JE, Block PC, McKay RG, et al. Transcatheter closure of ventricular septal defects. Circulation. 1988;78(2):361–368.
   PubMed Web of Science ®Google Scholar
• Rodriguez JC, Berdaoui B, Morissens M. Percutaneous closure of an iatrogenic inlet ventricular septal defect in an atrioventricular canal. JACC Case Rep. 2020;2(6):911–914.
   PubMedGoogle Scholar
• Barwad P, Prasad K, Dinakar B, et al. Percutaneous closure of small subpulmonic ventricular septal defect with an ADO I PDA occluder in a child. Ann Pediatr Cardiol. 2020;13(4):349–352.
   PubMed Web of Science ®Google Scholar
• Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015;132:2037–2099. DOI:10.1161/CIR.0000000000000329
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Wort SJ, Gatzoulis MA. Pulmonary hypertension related to congenital heart disease: a call for action. Eur Heart J. 2014;35(11):691–700.
   PubMed Web of Science ®Google Scholar
• Rao PS, Harris AD. Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects. F1000Res. 2018;7:F1000. Faculty Rev-498. DOI:10.12688/f1000research.14102.1
   PubMedGoogle Scholar
• Feltes TF, Bacha E, Beekman IR, et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease. Circulation. 2011;123(22):2607–2652. DOI:10.1161/CIR.0b013e31821b1f10
   PubMed Web of Science ®Google Scholar
• Kalra GS, Verma PK, Dhall A, et al. Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up. Am Heart J. 1999;138(2):339–344.
   PubMed Web of Science ®Google Scholar
• Amin Z, Berry JM, Foker JE, et al. Intraoperative closure of muscular ventricular septal defect in a canine model and application of the technique in a baby. J Thorac Cardiovasc Surg. 1998;115(6):1374–1376.
   PubMed Web of Science ®Google Scholar
• Tofeig M, Patel RG, Walsh KP. Transcatheter closure of a mid-muscular ventricular septal defect with an Amplatzer VSD occluder device. Heart. 1999;81(4):438.
   PubMed Web of Science ®Google Scholar
• AGA Medical Corporation. Summary of Safety and Effectiveness Data: AMPLATZER Muscular VSD Occluder [Internet]. 2007 [cited 2023 Mar 23]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf4/p040040b.pdf
   Google Scholar
• AGA Medical Corporation. Instructions for use: amplatzer post-infarct muscular VSD occluder [Internet]. 2017 [cited 2023 Mar 23]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf7/H070005D.pdf
   Google Scholar
• Mahmoud HT, Santoro G, Capogrosso C, et al. Off-label use of amplatzer duct occluder ii additional sizes. J Cardiovasc Med. 2017;18(6):436–442.
   Google Scholar
• Vijayalakshmi IB, Narasimhan C, Singh B, et al. Treatment of congenital non‐ductal shunt lesions with the amplatzer duct occluder II. Catheterization Cardiovasc Interventions. 2017;89(6):E185–93.
   PubMed Web of Science ®Google Scholar
• Kursaklioglu H, Barcin C, Iyisoy A, et al. Percutaneous closure of mitral paravalvular leak via retrograde approach: with use of the amplatzer duct occluder II and without a wire loop. Texas Heart Inst J PMID -. 2010;20844623(4):461–464.
   Google Scholar
• Abbott. AMPLATZER DUCT OCCLUDERS [Internet]. 2023 [cited 2023 Mar 23]. Available from: https://www.cardiovascular.abbott/us/en/hcp/products/structural-heart/structural-interventions/amplatzer-pda.html
   Google Scholar
• Knop MT, Litwin L, Szkutnik M, et al. Percutaneous closure of perimembranous and postsurgical ventricular septal defects with amplatzer duct occluder II additional sizes in paediatric patients – case series. Postepy Kardiol Interwencyjnej. 2018;14(4):429–432.
   PubMed Web of Science ®Google Scholar
• Tzikas A, Ibrahim R, Velasco‐sanchez D, et al. Transcatheter closure of perimembranous ventricular septal defect with the Amplatzer® membranous VSD occluder 2: initial world experience and one‐year follow‐up. Catheterization Cardiovasc Interventions. 2014;83(4):571–580. DOI:10.1002/ccd.25004
   PubMed Web of Science ®Google Scholar
• AGA Medical Corporation. Summary of safety and effectiveness Data: AMPLATZER Duct Occluder [Internet]. 2003 [cited 2023 Mar 23]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf2/p020024b.pdf
   Google Scholar
• Kalra GS, Verma PK, Singh S, et al. Transcatheter closure of ventricular septal defect using detachable steel coil. Heart. 1999;82(3):395.
   PubMed Web of Science ®Google Scholar
• Szkutnik M, Biatkowski J, Dymitrow L, et al. Problems that occurred during and after transcatheter closure of muscular ventricular septal defects in two patients. Advn Interventional Cardiol. 2009;5(2):58–61. InternetAvailable from. https://www.termedia.pl/Original-paper-Problems-that-occurred-during-and-after-transcatheter-closure-of-muscular-ventricular-septal-defects-in-two-patients,35,12677,1,1.html
   Google Scholar
• Khoshhal SQ, Al-Mutairi MB, Alnajjar AA, et al. Transcatheter device closure of ventricular septal defects in children: a retrospective study at a single cardiac center. Ann Saudi Med. 2020;40(5):396–402. DOI:10.5144/0256-4947.2020.396
   PubMed Web of Science ®Google Scholar
• Fischer G, Apostolopoulou SC, Rammos S, et al. The Amplatzer® membranous VSD occluder and the vulnerability of the atrioventricular conduction system. Cardiol Young. 2006;17(5):499–504.
   Web of Science ®Google Scholar
• Predescu D, Chaturvedi RR, Friedberg MK, et al. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008;136(5):1223–1228.
   PubMed Web of Science ®Google Scholar
• Bentham JR, Gujral A, Adwani S, et al. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block? Cardiol Young. 2011;21(3):271–280.
   PubMed Web of Science ®Google Scholar
• Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J. 2007;28(19):2361–2368. DOI:10.1093/eurheartj/ehm314
   PubMed Web of Science ®Google Scholar
• Saurav A, Kaushik M, Alla VM, et al. Comparison of percutaneous device closure versus surgical closure of peri‐membranous ventricular septal defects: a systematic review and meta‐analysis. Catheterization Cardiovasc Interventions. 2015;86(6):1048–1056. DOI:10.1002/ccd.26097
   PubMed Web of Science ®Google Scholar
• Zhou Y, Qin Y, Zhao X, et al. The impact of short or long transcatheter occluder waist lengths on postprocedure complete atrioventricular block: a retrospective study. J Invasive Cardiol. 2015;27(11):E231–5.
   PubMed Web of Science ®Google Scholar
• Udink ten Cate FEA, Sobhy R, Kalantre A, et al. Off‐label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: a multicenter experience. Catheterization Cardiovasc Interventions. 2019;93(1):82–88. DOI:10.1002/ccd.27792
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang W, Li J, et al. Transcatheter closure of perimembranous and intracristal ventricular septal defects using amplatzer duct occluder ii in children. J Interv Cardiol. 2021;2021:4091888.
   PubMed Web of Science ®Google Scholar
• Mijangos-Vázquez R, El-Sisi A, Jones JPS, et al. Transcatheter closure of perimembranous ventricular septal defects using different generations of amplatzer devices: multicenter experience. J Interv Cardiol. 2020;2020:8948249.
   PubMed Web of Science ®Google Scholar
• Narin N, Baykan A, Pamukcu O, et al. ADO II in percutaneous VSD closure in pediatric patients. J Interv Cardiol. 2015;28(5):479–484. DOI:10.1111/joic.12222
   PubMed Web of Science ®Google Scholar
• Bergmann M, Germann CP, Nordmeyer J, et al. Short- and long-term outcome after interventional vsd Closure: a Single-Center Experience in Pediatric and Adult Patients. Pediatr Cardiol. 2021;42(1):78–88.
   PubMed Web of Science ®Google Scholar
• Cen H, Peng B, Li J, et al. Efficacy and safety of the amplatzer duct occluder II for ventricular septal defect closure: a meta-analysis. Kardiol Pol. 2021;79(4):401–409. DOI:10.33963/KP.15762
   PubMed Web of Science ®Google Scholar
• Koneti NR, Sreeram N, Penumatsa RR, et al. Transcatheter retrograde closure of perimembranous ventricular septal defects in children with the amplatzer duct occluder II device. J Am Coll Cardiol. 2012;60(23):2421–2422.
   PubMed Web of Science ®Google Scholar
• Kozlik-Feldmann R, Lorber A, Sievert H, et al. Long-term outcome of perimembranous VSD closure using the nit-occlud® Lê VSD coil system. Clin Res Cardiol. 2021;110(3):382–390. DOI:10.1007/s00392-020-01750-6
   PubMed Web of Science ®Google Scholar
• Pillai AA, Rangasamy S, Balasubramonian VR. Transcatheter closure of moderate to large perimembranous ventricular septal defects in children weighing 10 kilograms or less. World J Pediatr Congenit Heart Surg. 2018;10(3):278–285.
   Web of Science ®Google Scholar
• Santhanam H, Yang L, Chen Z, et al. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol. 2018;254:75–83. DOI:10.1016/j.ijcard.2017.12.011
   PubMed Web of Science ®Google Scholar
• Lin L, Liu J, Guo X, et al. Risk factors for atrioventricular block after occlusion for perimembranous ventricular septal defect. Heart Rhythm. 2022;19(3):389–396. DOI:10.1016/j.hrthm.2021.11.027
   PubMed Web of Science ®Google Scholar
• Yang J, Yang L, Yu S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children a randomized controlled trial. J Am Coll Cardiol. 2014;63(12):1159–1168. DOI:10.1016/j.jacc.2014.01.008
   PubMed Web of Science ®Google Scholar
• Bacha EA, Cao QL, Starr JP, et al. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J Thorac Cardiovasc Surg. 2003;126(6):1718–1723.
   PubMed Web of Science ®Google Scholar
• Crossland DS, Wilkinson JL, Cochrane AD, et al. Initial results of primary device closure of large muscular ventricular septal defects in early infancy using perventricular access. Catheterization Cardiovasc Interventions. 2008;72(3):386–391.
   PubMed Web of Science ®Google Scholar
• Gray RG, Menon SC, Johnson JT, et al. Acute and midterm results following perventricular device closure of muscular ventricular septal defects: a multicenter PICES investigation. Catheterization Cardiovasc Interventions. 2017;90(2):281–289. DOI:10.1002/ccd.27121
   PubMed Web of Science ®Google Scholar
• Eckerström F, Nyboe C, Maagaard M, et al. Survival of patients with congenital ventricular septal defect. Eur Heart J. 2022;44(1):54–61.
   Web of Science ®Google Scholar
• Andersen HØ, Leval de MR, Tsang VT, et al. Is complete heart block after surgical closure of ventricular septum defects still an issue? Ann Thorac Surg. 2006;82(3):948–956.
   PubMed Web of Science ®Google Scholar
• Lin A, Mahle WT, Frias PA, et al. Early and delayed atrioventricular conduction block after routine surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2010;140(1):158–160. DOI:10.1016/j.jtcvs.2009.12.050
   PubMed Web of Science ®Google Scholar
• Liberman L, Pass RH, Hordof AJ, et al. Late onset of heart block after open heart surgery for congenital heart disease. Pediatr Cardiol. 2008;29(1):56–59.
   PubMed Web of Science ®Google Scholar
• Gabriels C, Backer De J, Pasquet A, et al. Long-term outcome of patients with perimembranous ventricular septal defect: results from the Belgian registry on adult congenital heart disease. Cardiol. 2017;136(3):147–155. DOI:10.1159/000448513
   PubMed Web of Science ®Google Scholar
• U.S. National Library of Medicine. Transcatheter versus surgical closure of ventricular septal defect: a comparative study [Internet]. 2022 [cited 2023 Mar 23]. Available from: clinicaltrials.gov
   Google Scholar